Conference Calendar

March 14-18 - American Association of Orthopaedic Medicine Annual Meeting 2017

March 14-December 31 - Canaccord Genuity Musculoskeletal Conference

Complete Calendar »

Earnings Calendar

No Upcoming Events Scheduled
Complete Calendar »

Read our research via:
email art

Weekly Email

rss art


app icon


app store icon


Orthopedic and Dental Industry News

November 2006

Allograft Teleseminar coming up-- December 6 BY EDITOR, NOVEMBER 30, 2006

We'd like to remind you that our Allograft teleseminar with our Research team and Jeff Sandler, an industry veteran, next week. Jeff will discuss the allograft industry, current issues and his advice for selecting a tissue bank. Report purchasers will... more

Orthopedic News Roundup 30-Nov-06 BY LAUREN UZDIENSKI, NOVEMBER 30, 2006

Earnings ORTHOsoft reported 3Q:06 revenues of CAN $3.8 million (US $3.3 million), up 59% from CAN $2.4 million (US $2.1 million) in 3Q:05. ORTHOsoft manufactures computer aided orthopedic surgery devices, and they attribute the 3Q:06 growth to increased navigation systems... more

Rutgers Researcher Seeks Credibility for Chinese Spine Trials BY LAUREN UZDIENSKI, NOVEMBER 29, 2006

In 2005, Nature reported that companies were "queuing up" to conduct clinical trials in China, where a large population simplifies the enrollment process and research could be conducted at lower cost than in the U.S. Similar trends can be seen... more

OIG Approves New Gainsharing Plan; AdvaMed Critical BY LAUREN UZDIENSKI, NOVEMBER 28, 2006

Earlier this month, the Office of the Inspector General (OIG) issued a new opinion over gainsharing. The cardiologist group who submitted the request received a favorable response, with the OIG determining that though the arrangement may violate the Social Seucrity... more

Insurer Begins Coverage of Dental Implants BY DAVID KRESSEL, NOVEMBER 27, 2006

Delta Dental of Michigan, Ohio and Indiana has announced it will offer coverage of dental implants as a part of its standard coverage package, beginning January 1, 2007. Specifically, patients will be able to choose between receiving a bridge or... more

Intial SPORT Trial Outcomes Subject to Interpretation, but Tend to Favor Surgery BY JOHN MCCORMICK, NOVEMBER 22, 2006

The first arm of the Spine Patients Outcome Research Trial ("SPORT") study was released by the Journal of the American Medical Association yesterday. The $13.5 million NIH funded SPORT study has been designed to determine the efficacy of spine surgery... more

Medtronic Sofamor Danek's Spinal Business Continues To Grow BY ARIELLA P. GOLOMB, MD, NOVEMBER 21, 2006

For 2Q:07, Medtronic reported overall revenue of $3.08 billion, which represented year over year growth of 11% (10% on a constant currency basis), beating analyst estimates of $2.97 billion. During the quarter spinal instrumentation generated revenues of $421 million, an... more

Ray Elliott To Retire From President and CEO Role at Zimmer BY ARIELLA P. GOLOMB, MD, NOVEMBER 20, 2006

Zimmer announced this morning that Ray Elliott is planning a 1H:07 retirement from his role as President and Chief Executive Officer. The Company also added that Mr. Elliott will remain as Chairman for at least one year from today. Elliott... more

Orthovita to Raise $23 Million BY JOHN MCCORMICK, NOVEMBER 17, 2006

This morning Orthovita announced that it hopes to do a 7.7 million share offering at $3.25 a share in order to raise approximately $23 million net of fees. At least $9 million of the proceeds is expected to be used... more

Orthopedic News Roundup 16-Nov-2006 BY LAUREN UZDIENSKI, NOVEMBER 16, 2006

Earnings: Langer reported their 3Q:06 results on Tuesday, which included a net loss of approximately $553,000, or $.06 per share on a fully diluted basis. Compared to 3Q:05, there was a net income $236,000, or $.02 per share on a... more

Pursuing Orthopedic Indications for Already-Marketed Pharmaceuticals BY ARIELLA P. GOLOMB, MD, NOVEMBER 15, 2006

There is a pattern worth recognizing in the orthopedics industry - companies are taking drugs already on the market and exploring new indications, specifically for orthopedic related applications. From a safety perspective, this model makes a lot of sense -... more

Evolving Devices for the High-Tech OR BY LAUREN UZDIENSKI, NOVEMBER 15, 2006

Furthering the trend of the interoperability of medical devices (emphasized at last week's MDMA meeting) is a pilot program headed by Massachusetts General Hospital and the Center for Integration of Medicine and Innovative Technology. The program features the use of... more

With a Democratic Congress, What's in Store for Medical Devices? BY LAUREN UZDIENSKI, NOVEMBER 14, 2006

With the Democrats taking over the House and Senate, new healthcare priorities are bound to emerge: an early target is pharma, specifically regarding legislation that would allow the government to negotiate directly with drug companies over prices as well as... more

MDMA Conference Provides Reimbursement Advice BY ARIELLA P. GOLOMB, MD, NOVEMBER 13, 2006

Last week we attended the 9th Annual MDMA Coverage Reimbursement and Health Policy Conference in Washington D.C. As we've previously discussed, the MDMA events are a terrific opportunity for small- to medium-sized device companies to network, provide insight on topical... more

INFUSE Moves into Dental BY JOHN CHOPACK, NOVEMBER 10, 2006

Medtronic, Inc. announced yesterday that the FDA Dental Products Advisory Panel had unanimously voted to recommend approval of INFUSE Bone Graft for certain oral and maxillofacial procedures. If the FDA agrees with that panel's recommendation, the US indications for INFUSE... more

Orthopedics News Roundup 9-Nov-06 BY LAUREN UZDIENSKI, NOVEMBER 10, 2006

Earnings: Tissue Grafting: Regeneration Technologies, Inc. announced revenues of $18.1 million for 3Q:06, compared to $22.5 million for 3Q:05. RTI said the decrease in revenues was due to fewer tissues available for processing demand and reduced orders from primary distributors.... more

The Cleveland Clinic Discusses Innovation BY JOHN MCCORMICK, NOVEMBER 9, 2006

This week we attended the Cleveland Clinic Medical Innovation Summit where industry luminaries gathered to discuss the future of medicine. The predominant themes were economics and advanced neurosciences. Notably, the ultimate form of evidence based medicine was highlighted: an elated... more

BioMimetic Therapeutics Releases Promising GEM OS1 Orthopedic Data BY ARIELLA P. GOLOMB, MD, NOVEMBER 8, 2006

GEM OS1 is BioMimetic Therapeutics' developmental product for open fracture reduction or fractures requiring surgery in orthopedic applications. The therapy consists of both particulate Beta-tricalcium phosphate (β-TCP) with recombinant human Platelet-Derived Growth Factor (rhPDGF-ββ). BioMimetic has a similar, already-marketed product,... more

Musculoskeletal Allograft Quiz BY EDITOR, NOVEMBER 8, 2006

February 2010 update: This report is no longer available for purchase. Learn more here. Even though processor scandals have tainted the allograft business, human bone graft isn't going away anytime soon. It's too important to spinal fusion and many other... more

Musculoskeletal Allograft in the U.S. Research Report - Sample Chapter BY EDITOR, NOVEMBER 8, 2006

February 2010 update: This report is no longer available for purchase. Learn more here. This is a sample chapter from our new research report on Allograft. Learn more about the report here, and purchase and download it for $279 from... more

Orthopedic News Roundup 2-Nov-06 BY HUYEN NGUYEN, NOVEMBER 3, 2006

Earnings Biologics: Orthovita reported 3Q:06 product sales came in at $11 million, up 32% compared to 3Q:05. Net loss for the quarter was $3.7 million, or a loss of $0.07 per share. The Company beat analysts' EPS estimates by $0.02,... more

New Technology May Revolutionize Device Development BY LAUREN UZDIENSKI, NOVEMBER 2, 2006

With limitations of time and money, designing a "perfect" medical device may be an unattainable goal. Practical limitations prompt designers stop at adequate designs lacking forseeable flaws - but new technology can give designers more freedom to test and develop... more

SNN Issued a Statement Re: BMET Acquisition Rumors BY HUYEN NGUYEN, NOVEMBER 2, 2006

This morning Smith & Nephew issued a statement confirming speculations that it has been speaking with Biomet. The Company stated that it, "it has held very preliminary talks with the US medical devices company, Biomet Inc. No agreement has been... more

Drug Trials Move to India, and Devices Are Next BY LAUREN UZDIENSKI, NOVEMBER 1, 2006

U.S. devicemakers face challenges in designing clinical trials, among them low recruitment rates and high costs. India may have the answer. Among the benefits, Pacific Bridge Medical reports in their November 2006 newsletter that cost savings can reach 40 to... more

Complete Archive